Euclidean Capital’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-40,257
Closed -$1.69M 13
2021
Q4
$1.69M Buy
+40,257
New +$1.69M 0.96% 11
2021
Q3
Sell
-25,866
Closed -$1.22M 15
2021
Q2
$1.22M Buy
25,866
+2
+0% +$95 0.4% 14
2021
Q1
$1.33M Buy
+25,864
New +$1.33M 0.44% 11